Back to Search
MEGAN REITZ, M.D.
M.D.
Family Medicine Physician
NPI: 1255483020IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MD00043869(WA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 2002
Research & Publications (20)
Excitatory and inhibitory purinergic control of neck muscle nociception in anaesthetized mice.
PMID 19126119·Cephalalgia·2009
7-preclinical
Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients.
PMID 19229537·Cancer Chemother Pharmacol·2009
8-other
Rapamycin enhances aplaviroc anti-HIV activity: implications for the clinical development of novel CCR5 antagonists.
PMID 19501260·Antiviral Res·2009
8-other
Investigations of enzyme-catalyzed reactions based on physicochemical descriptors applied to hydrolases.
PMID 19445497·J Chem Inf Model·2009
8-other
Increased expression of the tumor suppressor PLZF is a continuous predictor of long-term survival in malignant melanoma patients.
PMID 18771349·Cancer Biother Radiopharm·2008
8-other
Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients.
PMID 18084763·Cancer Chemother Pharmacol·2008
8-other
Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1.
PMID 19075241·Proc Natl Acad Sci U S A·2008
8-other
Peripheral blood neutrophils as independent immunologic predictor of response and long-term survival upon immunotherapy in metastatic renal-cell carcinoma.
PMID 18298337·Cancer Biother Radiopharm·2008
8-other
An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence.
PMID 18353949·J Virol·2008
7-preclinical
GM-CSF plus antigenic peptide vaccination in locally advanced melanoma patients.
PMID 17803450·Cancer Biother Radiopharm·2007
3-trial
Fractional polynomials in a new metastatic renal carcinoma continuous prognostic index involving histology, laboratory, and clinical predictors.
PMID 18158772·Cancer Biother Radiopharm·2007
8-other
Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model.
PMID 17263630·AIDS Res Hum Retroviruses·2007
7-preclinical
Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients.
PMID 17971774·Br J Cancer·2007
3-trial
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).
PMID 16909131·Br J Cancer·2006
4-observational
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma.
PMID 16636132·J Exp Med·2006
4-observational
An approach to estimating prognosis using fractional polynomials in metastatic renal carcinoma.
PMID 16736003·Br J Cancer·2006
8-other
Long-term maintenance therapy in interferon-alpha2a/interleukin-2-pretreated advanced renal-cell carcinoma patients.
PMID 16918296·Cancer Biother Radiopharm·2006
8-other
Suppression of MIP-1beta transcription in human T cells is regulated by inducible cAMP early repressor (ICER).
PMID 16443828·J Leukoc Biol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 125 16TH AVE E
SEATTLE, WA 98112 - Phone
- (206) 326-3530
Quick Facts
- NPI
- 1255483020
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile